Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Quotes

Date	Price	Change	Volume
26-08-07	€0.7300	+1.39%	193,876
26-08-06	€0.7200	-1.91%	151,245
26-08-05	€0.7340	-0.54%	198,112
26-08-04	€0.7380	+1.10%	71,140
26-08-03	€0.7300	+1.96%	138,352

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.7300EUR

Average target price

1.400EUR

Spread / Average Target

+91.78%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-08-07 EDT			5-day change	1st Jan Change
0.7300 ^EUR	+1.39%		+1.96%	-31.00%

07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI

Market Cap	50.29M 58.13M 46.96M 43.08M 81.03M 5.53B 82.31M 551M 216M 2.77B 218M 214M 9.17B	P/E 2026 *	-9.73x	P/E 2027 *	73x
Enterprise Value	61.44M 71.03M 57.37M 52.63M 98.99M 6.76B 101M 673M 264M 3.39B 267M 261M 11.2B	EV / Sales 2026 *	12x	EV / Sales 2027 *	4x
Free-Float	87.09%	Yield 2026 *	-	Yield 2027 *	-

07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
06-30	Amoéba gains from marketing authorization in France
06-30	Amoéba Bags Marketing Approval for Biofungicide in France	MT
06-30	Amoéba wins marketing authorization in France
06-08	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
06-08	Amoéba secures strategic emergency authorization in Italy
05-06	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
04-28	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
04-28	Amoéba secures emergency authorization for downy mildew treatment in France
04-13	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI
03-26	Amoéba Raises EUR7 Million via Private Placement	MT
03-26	Amoëba successfully completes capital increase

07-23	Amoéba : Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides	AT
07-01	Amoéba has received marketing authorization in France for its biofungicide AXPERA	GL
06-30	Amoéba : Amoéba has received marketing authorization in France for its biofungicide AXPERA	AT
06-08	Amoéba : Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew	AT
05-06	Amoéba : Two new exceptional trial permits in the Netherlands in 2026 for Amoéba’s biocontrol solution	AT

Amoéba Stock

Stocks

ALMIB

FR0011051598

Agricultural Chemicals

Valuation: Amoéba

Chart: Amoéba

Latest news : Amoéba

Press Releases: Amoéba

News in other languages: Amoéba

Quotes and Performance

Course Extremes

Managers and Directors: Amoéba

Latest insider transactions

Pesticide

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

07-23	Amoéba : Amoéba et Koppert étendent la durée de leur accord de distribution pour la technologie AXPERA et confirment leurs ambitions communes dans les biofongicides innovants
07-01	Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
07-01	Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
07-01	Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
07-01	Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

1 day	+1.39%
1 week	+1.96%
Current month	+1.96%
1 month	-4.58%
3 months	-21.67%
6 months	-20.39%
Current year	-31.00%

1 week	0.7	0.74
1 month	0.62	0.76
Current year	0.62	1.12
1 year	0.62	1.2
3 years	0.36	1.44
5 years	0.36	1.9
10 years	0.36	34.93

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	2023-12-13
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	2018-08-31
Hervé Testeil PRN	Corporate Officer/Principal	-	2022-02-28

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	2014-05-31
Benoît Villers CHM	Chairman	70	2023-12-13
Jean-luc Souche BRD	Director/Board Member	70	2023-05-24

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/30/26	Benoît Villers	Sell	Chairman	-31,100	0.0400%
5/23/25	Dominique Jean Francois Marie Doucet	Fiscal year	Chief Executive Officer	40,000	0.0805%
5/22/25	Dominique Jean Francois Marie Doucet	Fiscal year	Chief Executive Officer	560,000	1.1277%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	+1.39%	+1.96%	-13.61%	+20.46%	58.13M
JIANGSU YANGNONG CHEMICAL CO., LTD.	+0.49%	-2.72%	-14.78%	-24.00%	3.28B
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO.,LTD	+1.19%	+7.07%	+10.05%	-3.15%	2.21B
ADAMA LTD.	-1.27%	+1.88%	-21.30%	-35.97%	1.81B
LIER CHEMICAL CO.,LTD.	-1.47%	-11.38%	+14.83%	-0.07%	1.67B
CAC NANTONG CHEMICAL CO., LTD.	+0.04%	-0.62%	-23.85%	-	1.5B
ANHUI GUANGXIN AGROCHEMICAL CO., LTD.	+0.48%	-2.15%	-15.22%	-43.34%	1.41B
SHENZHEN NOPOSION CROP SCIENCE CO., LTD.	+0.22%	-1.40%	-27.80%	+35.01%	1.34B
NANTONG JIANGSHAN AGROCHEMICAL & CHEMICALS CO.,LTD.	-0.67%	-2.32%	-6.18%	-17.03%	1.32B
LIMIN GROUP CO.,LTD.	+3.84%	+24.22%	-27.93%	+86.96%	1.17B
Average	+0.42%	+1.80%	-12.58%	+2.10%	1.58B
Weighted average by Cap.	+0.27%	+1.00%	-11.17%	-5.92%

	2026 *	2027 *
Net sales	5.1M 5.9M 4.76M 4.37M 8.22M 561M 8.35M 55.88M 21.93M 281M 22.14M 21.66M 930M	15.55M 17.98M 14.52M 13.32M 25.06M 1.71B 25.45M 170M 66.87M 858M 67.51M 66.03M 2.83B
Net income	-5.2M -6.01M -4.86M -4.45M -8.38M -572M -8.51M -56.97M -22.36M -287M -22.57M -22.08M -948M	550K 636K 514K 471K 886K 60.51M 900K 6.03M 2.37M 30.33M 2.39M 2.34M 100M
Net Debt	11.15M 12.89M 10.41M 9.55M 17.97M 1.23B 18.25M 122M 47.95M 615M 48.41M 47.35M 2.03B	11.85M 13.7M 11.07M 10.15M 19.09M 1.3B 19.4M 130M 50.96M 653M 51.44M 50.32M 2.16B